Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

88
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
88
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

72
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
72
Tissue Transplantation01:24

Tissue Transplantation

567
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
567
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

544
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
544

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Short-term economic impact of early leaks following metabolic bariatric surgery.

The British journal of surgery·2026
Same author

Correction: Patient-Reported Outcomes and Quality of Life After Single-Anastomosis Duodeno-ileal Bypass with Sleeve Gastrectomy (SADI-S): a Cross-Sectional Study with 283 Patients from a Single Institution.

Obesity surgery·2026
Same author

Post-operative Metabolic Adaptation and its Influence on Long-Term Recurrent Weight Gain After Metabolic and Bariatric Surgery.

Obesity surgery·2026
Same author

Consensus statement on obesity management in liver transplantation candidates.

Updates in surgery·2026
Same author

Dexketoprofen-mediated attenuation of ischemia-reperfusion injury in a rat model of lower limb ischemia.

Cirugia espanola·2026
Same author

Cerebrospinal fluid and plasma leptin dynamics following bariatric surgery in women.

The Journal of clinical endocrinology and metabolism·2026

Related Experiment Video

Updated: Oct 8, 2025

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice
10:05

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice

Published on: March 20, 2017

12.2K

Bariatric Surgery and Solid-Organ Transplantation.

Amador García Ruiz de Gordejuela1, Ainitze Ibarzabal2, Javier Osorio3

  • 1Bariatric Surgery Unit, General Surgery Department, Vall d'Hebron University Hospital, Autonomous University of Barcelona, Barcelona, Spain.

Transplantation Proceedings
|January 2, 2022
PubMed
Summary

Bariatric surgery is an effective weight loss solution for patients with morbid obesity, including those with end-stage organ disease or post-transplant. It can treat obesity-related conditions and improve transplant eligibility and outcomes.

More Related Videos

Sleeve Gastrectomy in Mice using Surgical Clips
05:16

Sleeve Gastrectomy in Mice using Surgical Clips

Published on: November 14, 2020

6.8K
Robot-Assisted Kidney Transplantation
07:30

Robot-Assisted Kidney Transplantation

Published on: July 19, 2021

3.8K

Related Experiment Videos

Last Updated: Oct 8, 2025

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice
10:05

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice

Published on: March 20, 2017

12.2K
Sleeve Gastrectomy in Mice using Surgical Clips
05:16

Sleeve Gastrectomy in Mice using Surgical Clips

Published on: November 14, 2020

6.8K
Robot-Assisted Kidney Transplantation
07:30

Robot-Assisted Kidney Transplantation

Published on: July 19, 2021

3.8K

Area of Science:

  • Medical Science
  • Surgical Procedures
  • Obesity Medicine

Background:

  • Morbid obesity and overweight are global health issues impacting general populations and those with end-stage organ disease or post-transplant.
  • Obesity presents challenges for transplant candidacy and post-transplant health, affecting outcomes.
  • Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are liver conditions exacerbated by obesity, potentially leading to transplantation.

Purpose of the Study:

  • To evaluate the role and effectiveness of bariatric surgery in managing morbid obesity.
  • To explore bariatric surgery's utility in patients with end-stage solid-organ disease, both pre- and post-transplant.
  • To identify specific considerations and challenges associated with bariatric surgery in transplant populations.

Main Methods:

  • Review of existing literature on bariatric surgery outcomes in obese patients.
  • Analysis of bariatric surgery's impact on obesity-related comorbidities.
  • Examination of patient selection criteria and surgical considerations for transplant candidates and recipients.

Main Results:

  • Bariatric surgery is the most effective weight loss procedure, improving or reversing conditions like NAFLD/NASH.
  • It can facilitate transplant access by addressing obesity as a contraindication.
  • Post-transplant, bariatric surgery can manage obesity and related comorbidities, though specific challenges exist.

Conclusions:

  • Bariatric surgery offers significant benefits for weight management in obese patients, including those with end-stage organ disease and transplant recipients.
  • Careful consideration of increased risks (morbidity, mortality) and post-transplant factors (immunosuppression, technical issues) is crucial for successful outcomes.
  • Bariatric surgery serves as a vital tool for improving health and transplant outcomes in the context of obesity.